To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
GRI to Distribute Kreatech’s ULS in the United Kingdom and France
Kreatech Biotechnology BV and GRI have announced a partnership whereby GRI will exclusively supply Kreatech’s ULS™ solutions to laboratories in the United Kingdom and France.
The partnership will expand access of Kreatech’s non-enzymatic nucleic acid labeling solutions to life science investigators in the UK and France
The Universal Linkage System (ULS) is a platinum-based labeling technology that is designed to allow labeling of fluorophores or haptens directly to biomolecules such as RNA, DNA and proteins.
Because ULS is a chemical labeling technology, complete control over the labeling process has been achieved.
"This agreement expands our reach by leveraging GRI’s strong sales and marketing team in the UK and France," said Alexander Altink, Kreatech’s CEO.
"We look forward to working with GRI and expanding our international distribution network which now covers 21 countries world wide including; USA (Open Biosystems), Japan (Funakoshi), Germany (Biocat) and the Benelux (BioKe)."
Dr Martin Biggs, Marketing Manager of GRI says, "GRI are extremely excited to represent Kreatech Biotechnology in both the UK and France."
"As labeling and detection of molecules is fundamental to our customer’s research and their ultimate success. Kreatech's unique ULS labeling technology is the perfect fit to GRI's range of products."
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
